Endcap
Sign inJoin
GLP-1ActiveCloses in 12 months on May 16, 2027
Share / Embed

Generic GLP-1 launch in US: Q1 2026

42%YES chance
Yes
42%
No
58%

Now 42.4%

Resolution

Resolves to the quarter the first FDA-approved generic GLP-1 (semaglutide or tirzepatide) launches in the US.

Source: https://www.fda.gov/

Resolves by May 23, 2027.

Recent trades

  • NO@reesekhan
    37.1 sh@ 42%21 SP
  • NO@sagecarrillo
    70.3 sh@ 44%38 SP
  • NO@skylerunderhill
    154.9 sh@ 48%75 SP
  • YES@logantorres
    155.1 sh@ 55%80 SP
  • YES@harperyoon
    162.4 sh@ 48%71 SP
  • NO@tatumkim
    26.9 sh@ 40%16 SP
  • YES@emersonhayes
    79 sh@ 41%31 SP
  • NO@micahashworth
    53.8 sh@ 37%33 SP
  • NO@kaiunderhill
    82.6 sh@ 40%48 SP
  • YES@kaidiaz
    58.9 sh@ 44%25 SP
  • NO@lanechen
    59.1 sh@ 41%34 SP
  • NO@grayhale
    106.5 sh@ 44%57 SP
  • NO@rowandiaz
    79.8 sh@ 49%39 SP
  • NO@alexshah
    153 sh@ 53%66 SP
  • YES@parkersantos
    139.9 sh@ 61%80 SP
  • NO@elliskhan
    76.7 sh@ 54%34 SP
  • YES@tatumjensen
    31.7 sh@ 58%18 SP
  • YES@rowanmonroe
    120.7 sh@ 56%64 SP

Top holders

YES holders

No holders yet.

NO holders

No holders yet.

News

Refreshed every 6 hours

No news yet. Endcap's news crawler refreshes every 6 hours.

Discussion

  • @sashahayesSasha Hayes23 days ago

    this is the trade.